<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402304/" ref="ordinalpos=1773&amp;ncbi_uid=5140357&amp;link_uid=PMC3402304" image-link="/pmc/articles/PMC3402304/figure/F6/" class="imagepopup">FIG. 6. From: G Protein-Coupled Receptor Kinase 2, With ?-Arrestin 2, Impairs Insulin-Induced Akt/Endothelial Nitric Oxide Synthase <span class="highlight" style="background-color:">Signaling</span> in ob/ob Mouse Aorta. </a></div><br /><div class="p4l_captionBody">Proposed model of GRK2-mediated inhibition of Akt/eNOS pathway in diabetes. In normal aortas, binding of insulin to IR activates Akt/eNOS pathway via β-arrestin 2 (βarr2) activation, and GRK2 is not translocated. In diabetes, however, GRK2, which is present in increased quantities, binds to Akt (and βarr2 is not activated). This leads to reductions of Akt/eNOS signaling and NO production in the membrane.</div></div>